Novo Nordisk’s Obesity Drug Launched in Thailand

Novo Nordisk’s Obesity Drug Launched in Thailand

Novo Nordisk has introduced its weight-loss drug Wegovy in Thailand, marking the medication’s first launch in Southeast Asia. First released in 2021, Wegovy significantly contributed to Novo Nordisk’s valuation, which reached up to USD 615 billion at its peak, making...